Efficacy of Remimazolam besylate for intravenous sedation in dental procedures for patients with cognitive disabilities: a prospective single-arm observational study
Giovanni Battista Grossi, Gregorio Menozzi, Matteo Pellegrini, Marco Carraro, Laura Rey, Angela Galeotti, Andrea Scribante, Anna Papaleo, Giuseppe Sofi · 2026
Read Efficacy of Remimazolam besylate for intravenous sedation in dental procedures for patients with cognitive disabilities: a prospective single-arm observational study by Giovanni Battista Grossi, Gregorio Menozzi, Matteo Pellegrini, Marco Carraro, Laura Rey, Angela Galeotti, Andrea Scribante, Anna Papaleo, Giuseppe Sofi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13563919.txt.
Description
Giovanni Battista Grossi leads a 2026 study of intravenous remimazolam sedation for dental care in 43 adults with cognitive or motor disabilities at one center. Many such patients often need general anesthesia because cooperation is hard and risks are higher. A lighter option was tested under set guidelines.
Every procedure was completed without an anesthesiologist stepping in or a reversal drug being used. Sedation began in under four minutes on average, vital signs stayed stable, and no breathing problems occurred. Caregivers mostly reported calm behavior that day and normal sleep that night. Dentists get useful dosing and recovery figures for a group often left out of sedation research.
Catalog record
| CREATOR | Giovanni Battista Grossi, Gregorio Menozzi, Matteo Pellegrini, Marco Carraro, Laura Rey, Angela Galeotti, Andrea Scribante, Anna Papaleo, Giuseppe Sofi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 39276 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |